Fused ring nk1 antagonists

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 471/04 (2006.01) A61K 31/4355 (2006.01) A61K 31/437 (2006.01) A61K 31/4375 (2006.01) C07D 498/04 (2006.01)

Patent

CA 2562138

A compound having the general structure shown in Formula (1) or pharmaceutically acceptable salts and/or solvates thereof are useful in treating diseases or conditions mediated by NK1 receptors, for example various physiological disorders, symptoms or diseases, including emesis, depression, anxiety and cough.

Composé de structure générale représenté par la formule (I) ou sels pharmaceutiquement acceptables et/ou solvates de ce composé, convenant pour le traitement de pathologies ou d'états induits par des récepteurs NK1 tels que divers troubles physiologiques, symptômes ou maladies dont les vomissements, la dépression, l'anxiété ou la toux.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Fused ring nk1 antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Fused ring nk1 antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Fused ring nk1 antagonists will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-2006884

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.